The authors reply
- PMID: 35311793
- DOI: 10.1097/CCM.0000000000005457
The authors reply
Conflict of interest statement
Dr. Leonard’s institution received funding from the National Institutes of Health (NIH) and UpToDate. Dr. Gaines disclosed that she has been appointed to the medical board of Teleflex. Dr. Josephson’s institution received funding from Medtronics; she received funding from Westat LLC; she received support for article research from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study.Crit Care Med. 2022 Apr 1;50(4):e382-e392. doi: 10.1097/CCM.0000000000005383. Crit Care Med. 2022. PMID: 34661553
-
Bringing Hidden Biases Into Light: Comments on an Observational Study on the Use of Antifibrinolytics for Pediatric Patients With Life-Threatening Hemorrhage.Crit Care Med. 2022 Apr 1;50(4):e407-e408. doi: 10.1097/CCM.0000000000005421. Crit Care Med. 2022. PMID: 35311792 No abstract available.
References
-
- Sasaki R, Aita T, Nagano H, et al.: Bringing Hidden Biases Into Light: Comments on an Observational Study on the Use of Antifibrinolytics for Pediatric Patients With Life-Threatening Hemorrhage. Crit Care Med 2022; 50:e407–e408
-
- Spinella PC, Leonard JC, Gaines BA, et al.: MAssive Transfusion epidemiology and outcomes In Children (MATIC) Investigators and BloodNet: Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study. Crit Care Med 2022; 50:e382–e391
-
- Leonard JC, Josephson CD, Luther JF, et al.: Life-threatening bleeding in children: A prospective observational study. Crit Care Med 2021; 49:1943–1954
-
- Shroyer MC, Griffin RL, Mortellaro VE, et al.: Massive transfusion in pediatric trauma: Analysis of the National Trauma Databank. J Surg Res 2017; 208:166–172
Publication types
LinkOut - more resources
Full Text Sources